Home › Germ Cell and Embryonal Cancer
Pag-aaral pangklinika para sa Germ Cell and Embryonal Cancer na nagre-recruit sa U.S.
21 pag-aaral para sa Germ Cell and Embryonal Cancer ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX6 pag-aaral
- Columbus, OH5 pag-aaral
- New York City, NY5 pag-aaral
- Indianapolis, IN4 pag-aaral
- Chicago, IL4 pag-aaral
- St. Louis, MO4 pag-aaral
- Minneapolis, MN3 pag-aaral
- Clifton, NJ3 pag-aaral
- San Francisco, CA3 pag-aaral
- Mountain View, CA3 pag-aaral
- Winston-Salem, NC3 pag-aaral
- Greenburgh, NY3 pag-aaral
- Los Angeles, CA3 pag-aaral
- San Bernardino, CA3 pag-aaral
- Dallas, TX3 pag-aaral
- Boston, MA3 pag-aaral
- San Antonio, TX3 pag-aaral
- Memphis, TN3 pag-aaral
Ayos sa estado
- California7 pag-aaral
- Florida3 pag-aaral
- Georgia3 pag-aaral
- Illinois4 pag-aaral
- Indiana4 pag-aaral
- Massachusetts3 pag-aaral
- Michigan3 pag-aaral
- Minnesota3 pag-aaral
- Missouri4 pag-aaral
- New Jersey4 pag-aaral
- New York6 pag-aaral
- North Carolina3 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania3 pag-aaral
- Tennessee4 pag-aaral
- Texas7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Molecular Epidemiology of Pediatric Germ Cell Tumors
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05564026Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Nob 10, 2026 · NCT06828185Germ Cell Tumor and Testicular Tumor DNA Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT02099734Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 15 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06276491A Study of ZW251 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07164313HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Nagre-recruitPhase 3
Edad 11 hanggang 50 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03067181Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Nagre-recruitPhase 1/2
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05092451C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Nagre-recruitPhase 1
12 Months – 25 Years · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT04099797Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07628634A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06866964Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nagre-recruitPhase 1/2
Edad 4 hanggang 39 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT05278208A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update May 19, 2026 · NCT04897321Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT04804007A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Nagre-recruitMaagang Phase 1
Edad 3 hanggang 21 · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT07017816Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04308330The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT01890486Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Nagre-recruitPhase 1
Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT04185038Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT06937866Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.